# ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis

> **NCT07712835** · — · COMPLETED · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 22 (actual)

## Conditions studied

- ECMO Outcomes
- Respiratory Failure (Pediatric Patients)
- Malignancies, Hematologic
- Solid Tumor Malignancies
- Hematopoetic Stem Cell Transplant

## Interventions

- **OTHER:** Extracorporeal membrane oxygenation (ECMO)

## Key facts

- **NCT ID:** NCT07712835
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2024-12
- **Final completion:** 2025-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07712835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07712835, "ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07712835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*